Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
5 startups looking to compete in the obesity space
BioSpace
Mon, 07/22/24 - 12:03 pm
startups
obesity
weight loss
Metsera
35Pharma
ProFound Therapeutics
Metaphore
EraCal Therapeutics
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Motley Fool
Sun, 07/21/24 - 11:02 pm
Pfizer
obesity
weight loss
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?
BioSpace
Tue, 07/16/24 - 12:11 pm
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
weight loss
Pfizer moves forward with once-daily version of weight loss pill after setbacks
CNBC
Thu, 07/11/24 - 11:57 am
Pfizer
weight loss
danuglipron
Most patients stop using Wegovy, Ozempic for weight loss within two years
Reuters
Wed, 07/10/24 - 11:04 am
Novo Nordisk
Wegovy
Ozempic
weight loss
patients
Ozempic's popularity leads to shortages for people with Type 2 diabetes
NPR
Wed, 07/10/24 - 11:01 am
Novo Nordisk
diabetes
Ozempic
weight loss
drug shortages
Weight-loss drugs could become a test case for AI
Axios
Tue, 07/9/24 - 09:24 pm
artificial intelligence
weight loss
obesity
GLP-1 agonist
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
BioSpace
Tue, 07/9/24 - 11:51 am
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
weight loss
Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug prices
Fierce Pharma
Tue, 07/2/24 - 11:46 am
Joe Biden
Bernie Sanders
Novo Nordisk
Eli Lilly
drug pricing
diabetes
weight loss
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
Motley Fool
Sun, 06/30/24 - 09:56 pm
Altimmune
Novo Nordisk
Wegovy
weight loss
pemvidutide
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models
BioSpace
Mon, 06/24/24 - 11:24 am
NeuroBo Pharmaceuticals
DA-1726
ADA
weight loss
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool
Mon, 06/17/24 - 11:38 am
Structure Therapeutics
weight loss
Novo Nordisk
obesity
GS-1290
GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:48 am
GLP-1 agonists
Novo Nordisk
Eli Lilly
obesity
weight loss
The Ozempic craze is coming for dogs and cats next
Quartz
Fri, 06/14/24 - 11:17 am
animal health
Okava Pharmaceuticals
OKV-119
weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market
BioSpace
Tue, 06/11/24 - 11:27 am
Syntis Bio
obesity
weight loss
SYNT-101
Merck looks for next-generation opportunities in cardiometabolic drugs
Reuters
Tue, 06/11/24 - 11:23 am
Merck
cardiometabolic diseases
weight loss
Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Medical Marketing and Media
Tue, 06/4/24 - 11:48 am
Novo Nordisk
Wegovy
weight loss
obesity
DTC advertising
Structure Therapeutics pill leads to competitive weight loss in obesity study
BioPharma Dive
Mon, 06/3/24 - 10:26 pm
Structure Therapeutics
obesity
weight loss
GSBR-1290
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »